Login / Signup

Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization.

Damiano D'ArdesClaudia CarrariniMirella RussoFedele DonoRino SperanzaAnna DigiovanniGiovanni MartinottiAngelo Di IorioMarco OnofrjFrancesco CipolloneLaura Bonanni
Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2020)
The use of LMWH may help preventing the occurrence of delirium in COVID-19 patients, with possible reduction of length of stay in the hospital and sequelae.
Keyphrases
  • sars cov
  • cardiac surgery
  • coronavirus disease
  • hip fracture
  • risk assessment
  • venous thromboembolism
  • healthcare
  • respiratory syndrome coronavirus
  • acute kidney injury
  • growth factor
  • acute care
  • mouse model
  • adverse drug